Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors

Clinical and Experimental Dermatology

Volumn 39, Issue 1, 2014, Pages 19-24

  Li, R C ^a   Krishnamoorthy, P ^a   Derohannessian, S ^a   Doveikis, J ^a   Wilcox, M ^a   Thomas, P ^b   Rader, D J ^a   Reilly, M P ^a   Van Voorhees, A ^b   Gelfand, J M ^a,b   Mehta, N N ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BODY SURFACE; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; RANDOM SAMPLE; SMOKING; SYSTEMIC THERAPY; TOPICAL TREATMENT; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSORIASIS; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84890445846     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12250     Document Type: Article

References (22)

1. Love TJ, Qureshi AA, Karlson EW, et al,. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol 2011; 147: 419-24.
2. Gelfand JM, Neimann AL, Shin DB, et al,. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-41.
3. Krueger JG,. Hiding under the skin: a welcome surprise in psoriasis. Nat Med 2012; 18: 1750-1.
4. Ahmed M, Gaffen SL,. IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev 2012; 21: 449-53.
5. Shibata S, Saeki H, Tada Y, et al,. Serum high molecular weight adiponectin levels are decreased in psoriasis patients. J Dermatol Sci 2009; 55: 62-3.
6. Cerman AA, Bozkurt S, Sav A, et al,. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol 2008; 159: 820-6.
7. Tilg H, Moschen AR,. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772-83.
8. Abdel Hay RM, Rashed L,. Association between the leptin gene 2548G/A polymorphism, the plasma leptin and the metabolic syndrome with psoriasis. Exp Dermatol 2011; 20: 715-19.
9. Qasim A, Mehta NN, Tadesse MG, et al,. Adipokines, insulin resistance, and coronary artery calcification. J Am Coll Cardiol 2008; 52: 231-6.
10. Gregor MF, Hotamisligil GS,. Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res 2007; 48: 1905-14.
11. Fasshauer M, Kralisch S, Klier M, et al,. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2003; 301: 1045-50.
12. Anderson PD, Mehta NN, Wolfe ML, et al,. Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab 2007; 92: 2272-9.
13. Reilly MP, Wolfe ML, Rhodes T, et al,. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 2004; 110: 803-9.
14. Weisberg SP, Mccann D, Desai M, et al,. Obesity is associated with macrophage accumulation. J Clin Invest 2003; 112: 1796-808.
15. Lumeng CN, Bodzin JL, Saltiel AR,. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-84.
16. Shibata S, Tada Y, Hau C, et al,. Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy. Br J Dermatol 2011; 164: 667-70.
17. Mehta NN, Azfar RS, Shin DB, et al,. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 2010; 31: 1000-6.
18. Mehta NN, Yu Y, Pinnelas R, et al,. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 2011; 124: e1-6.
19. Mehta NN, Yu Y, Saboury B, et al,. Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]- fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Arch Dermatol 2011; 147: 1031-9.
20. Mehta NN, Li R, Krishnamoorthy P, et al,. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. Atherosclerosis 2012; 224: 218-21.
21. Hansson GK,. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95.
22. Al-Attas OS, Hussain T, Al-Daghri NM, et al,. The relationship between a Mediterranean diet and circulating adiponectin levels is influenced by cigarette smoking. J Atheroscler Thromb 2013; 20: 313-20.